Market Intelligence Ecosystem
IOL Chemicals and Pharmaceuticals Limited (NSE:IOLCP) Q2 FY23 Earnings Concall dated Nov. 15, 2022 Corporate Participants: Sanjay Chaturvedi -- Executive Director and Chief Executive
Biocon Limited (NSE: BIOCON) Q2 FY23 Earnings Concall dated Nov. 14, 2022 Corporate Participants: Saurabh Paliwal -- Head, Investor Relations Kiran Mazumdar
Glenmark Pharmaceuticals Limited (NSE: GLENMARK) Q2 FY23 Earnings Concall dated Nov. 13, 2022 Corporate Participants: Utkarsh Gandhi -- General Manager - Investor Relations Brendan
Alembic Pharmaceuticals Limited (NSE:APLLTD) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Raj Kumar Baheti -- Director - Finance and Chief Financial
Healthcare Global Enterprises Ltd (NSE:HCG) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: B.S. Ajai Kumar -- Executive Chairman Raj
Indoco Remedies Limited (NSE:INDOCO) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Aditi Panandikar -- Managing Director Sundeep Bambolkar --
Dishman Carbogen Amcis Ltd (NSE: DCAL) Q2 FY22 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Arpit Vyas -- Global Managing Director Pascal Villemagne -- Vice
Aster DM Healthcare Limited (NSE:ASTERDM) Q2 FY23 Earnings Concall dated Nov. 11, 2022 Corporate Participants: Azad Moopen -- Chairman & Managing Director
https://youtu.be/-5pgj3qU44c Key highlights from Sequent Scientific Limited (SEQUENT) Q2 FY23 Earnings Concall Q&A Highlights: [00:17:40] Rishab Jain asked about Tineta Pharma acquisition,
Zydus Wellness Ltd (NSE:ZYDUSWELL)Q2 FY23 Earnings Concall dated Nov. 10, 2022 Corporate Participants: Tarun Arora -- Chief Executive Officer, Whole Time Director
Dr Lal PathLabs Ltd (NSE:LALPATHLAB) Q2 FY23 Earnings Concall dated Nov. 08, 2022 Corporate participants: Arvind Lal -- Executive Chairman Om Prakash
Max Healthcare Institute Ltd (NSE:MAXHEALTH) Q2 FY23 Earnings Concall dated Nov. 02, 2022 Corporate Participants: Suraj Digawalekar -- CDR India Investor Relations
Gland Pharma Limited (NSE:GLAND) Q2 FY23 Earnings Concall dated Oct. 26, 2022 Corporate Participants: Sumanta Bajpayee — Vice President, Corporate Finance and Investor Relations
Aarti Drugs Ltd. (NSE:AARTIDRUGS) Q2 FY23 Earnings Concall dated Oct. 21, 2022 Corporate Participants: Adhish P. Patil -- Chief Financial Officer Vishwa Savla -- Managing Director
Stock Data: TickerAPOLLOHOSPExchangeBSE and NSE IndustryHealthcare Why is the stock price rising? Shares of Apollo Hospitals Enterprise Ltd have gained 8.84% over the
Divi's Laboratories Ltd (NSE:DIVISLAB) Q1 FY23 Earnings Concall dated Aug. 12, 2022 Corporate Participants: Satish Choudhury -- Company Secretary and Chief Investor
Nava Bharat Ventures Limited (BSE: NBVENTURES) Q1 FY23 Earnings Concall dated Aug.12, 2022 Corporate Participants: Ashwin Devineni -- Chief Executive Officer Analysts: Mohit Kumar -- DAM
Hikal Limited (NSE:HIKAL) Q2 FY23 Earnings Concall dated Aug. 11, 2022 Corporate Participants: Sameer Hiremath -- Managing Director Manoj Mehrotra -- President-Pharmaceuticals Vimal
Orchid Pharma Ltd (NSE:ORCHPHARMA) Q1 FY23 Earnings Concall dated Aug. 10, 2022 Corporate Participants: Mridul Dhanuka -- Executive Director Sunil Kumar Gupta --
https://youtu.be/02Igs_HUAfo Key highlights from Glenmark Life Sciences Limited (GLS) Q1 FY23 Earnings Concall Q&A Highlights: [00:14:56] Neha Manpuria from Bank of America
Rainbow Children's Medicare Ltd (NSE:RAINBOW) Q2 FY23 Earnings Concall dated Aug. 09, 2022 Corporate Participants: Siddharth Rangnekar -- Investor Relations Ramesh Kancharla